Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Signs an Authorized Sales Agent Agreement with Irudigi

TheNewsWire May 15, 2019

Ventripoint to Exhibit VMS+ 3.0 at the Canadian Society of Echocardiography 21st Annual Symposium

TheNewsWire April 1, 2019

Canada's Largest Heart Health Centre Orders VMS+ Complete Heart Analysis System

TheNewsWire March 25, 2019

Ventripoint Provides Live Demonstrations of the VMS+3.0 System at American College of Cardiology 68th Annual Conference

TheNewsWire March 19, 2019

Ventripoint Announces TSXV Approval of Extension of Warrants and Clarifies Warrants Subject to Extension

TheNewsWire March 14, 2019

Ventripoint Announces Press Release Correction

TheNewsWire March 6, 2019

Ventripoint Announces Extension of Warrants

TheNewsWire March 6, 2019

Ventripoint's VMS System Approved for Sale and Clinical Use in China

TheNewsWire March 5, 2019

IIROC Trading Resumption - VPT

Canada NewsWire March 4, 2019

IIROC Trading Halt - VPT

Canada NewsWire March 4, 2019

Ventripoint's VMS System Approved for Sale and Clinical Use in China

TheNewsWire March 4, 2019

Ventripoint to Exhibit the VMS+ 3.0 System at American College of Cardiology Annual Conference and Grant of Options

TheNewsWire February 27, 2019

Ventripoint Diagnostics Reports Progress of the Next-Generation VMS+ 3.0 System and Remote Workstation

TheNewsWire February 5, 2019

Ventripoint Announces Closing of Non-Brokered Debenture Unit Private Placement

TheNewsWire January 28, 2019

Ventripoint Awarded MDSAP Certification, the Highest Quality Standards in the Medical Device Industry

TheNewsWire January 22, 2019

Ventripoint Announces Increase in Non-Brokered Debenture Unit Private Placement

TheNewsWire January 21, 2019

Ventripoint Announces $1,000,000 Non-Brokered Debenture Unit Private Placement

TheNewsWire January 9, 2019

St. Antonius Hospital in Nieuwegein Utrecht, The Netherlands Has Studied 500 Sarcoidosis Patients Using the Ventripoint Heart-Analysis System

TheNewsWire January 7, 2019

Ventripoint Performs Live Demonstrations of the Next-Generation VMS+ System at EuroEcho 2018

TheNewsWire December 14, 2018

Ventripoint Announces CEO to Give Medical Keynote Presentation at Wall Street Conference in January and Engagement of Lyons Capital LLC

TheNewsWire December 13, 2018